SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TELK -- Telik, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: LJM12/28/2006 12:04:34 PM
  Read Replies (2) of 887
 
<TELK SNIP FROM ARTICLE RE: Black Bear>

Indie Research
Making Noise: The 2006 Noisey Awards - Part 2
Thursday December 28, 9:35 am ET
By Ben Silverman, FindProfit.com

I Hope They're Hedged Award: The implosion of biotech firm Telik Inc. (Nasdaq: TELK - News) was a rude, unwanted, late Christmas gift for many investors, but none more so than Eastbourne Capital Management, which owns about 13 million shares of the stock, or an almost 25% stake in the company. From February 24th to December 22nd, Eastbourne, through its Black Bear Offshore Master Fund LP, bought approximately 3.7 million shares of Telik at an average price of $16.90, or an investment of about $65 million. Eastbourne is down more than -72% on that position alone, and based on the firm's historic holdings of Telik and Telik's historic stock price, the firm looks to be anywhere from $150 million to $200 million in the red on the position.

<SNIP>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext